Drug Profile
Research programme: ileal bile acid transport inhibitors - Asahi Kasei Pharma
Alternative Names: AK-105Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Asahi Kasei Pharma Corp
- Class
- Mechanism of Action Sodium-bile acid cotransporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hypercholesterolaemia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Hypercholesterolaemia in Japan
- 03 Aug 2006 This programme is still in active development
- 14 Jul 2004 Preclinical trials in Hypercholesterolaemia in Japan (unspecified route)